THE Senate’s Community Affairs
Committee has recommended an
increase in the threshold for Federal
Cabinet approval for new medicines
to be listed on the Pharmaceutical
Benefits Scheme - along with an
indexing of the level to keep it up to
date with inflation.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 25 Nov 10
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Nov 10
